Adrian Senderowicz Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adrian Senderowicz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adrian Senderowicz. Adrian Senderowicz is a SVP, Chief Medical Officer in Cerulean Pharma Inc. ($CERU) and a Director in PUMA BIOTECHNOLOGY, INC. ($PBYI) and a Chief Medical Officer in CONSTELLATION PHARMACEUTICALS INC ($CNST) and a Chief Medical Officer in Ignyta, Inc. ($RXDX).
Address: C/O IGNYTA, INC. 11095 FLINTKOTE AVENUE, SUITE D SAN DIEGO 92121 CA
Companies in which Adrian Senderowicz is an Insider
CONSTELLATION PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adrian Senderowicz: Chief Medical Officer
Holdings: 25,241 shares
Latest Transaction: May 13 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dare Bioscience, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adrian Senderowicz: SVP, Chief Medical Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 09 2017
$DARE Market Capitalization: $36.49M
$DARE Previous Close: $1.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ignyta, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adrian Senderowicz: Chief Medical Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 09 2015
$RXDX Market Capitalization: $243.66M
$RXDX Previous Close: $5.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PUMA BIOTECHNOLOGY, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adrian Senderowicz: Director
Holdings: 40,993 shares
Current Value: $1,387,613
Latest Transaction: Jun 15 2020
$PBYI Market Capitalization: $1.37B
$PBYI Previous Close: $33.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Adrian Senderowicz
Sentiment: All, CNST, DARE, RXDX, PBYI
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2020 | PBYI | PUMA BIOTECHNOLOGY ... | Senderowicz Adrian | Director | Sell | S | 9.89 | 10,000 | 98,878 | 40,993 | 51 K to 41 K (-19.61 %) |
| Jun 11 2020 | PBYI | PUMA BIOTECHNOLOGY ... | Senderowicz Adrian | Director | Grant | A | 0.00 | 25,748 | 0 | 50,993 | 25.2 K to 51 K (+101.99 %) |
| May 13 2020 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Option Exercise | M | 5.51 | 9,357 | 51,557 | 99,663 | |
| May 13 2020 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Sell | S | 50.18 | 9,357 | 469,488 | 15,884 | 25.2 K to 15.9 K (-37.07 %) |
| May 13 2020 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Buy | M | 5.51 | 9,357 | 51,557 | 25,241 | 15.9 K to 25.2 K (+58.91 %) |
| Nov 08 2019 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Option Exercise | M | 5.51 | 27,232 | 150,048 | 109,020 | |
| Nov 08 2019 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Sell | S | 35.11 | 5,451 | 191,394 | 15,884 | 21.3 K to 15.9 K (-25.55 %) |